4D Medicine Reports Minimal Bioburden in Pre-Sterilisation Testing
4D Medicine has confirmed that material pre-sterilisation bioburden testing has demonstrated minimal colony forming unit (CFU) counts.
These results highlight the strong control of manufacturing conditions and reinforce the company’s commitment to maintaining high standards of cleanliness and quality ahead of sterilisation processes.
This outcome supports ongoing product safety and regulatory compliance across 4D Medicine’s development programmes.
